| Literature DB >> 31532802 |
Silke Stjerneklar1, Esben Hougaard1, Lauren F McLellan2, Mikael Thastum1.
Abstract
BACKGROUND: Anxiety disorders are highly prevalent in adolescence, but access to health care services is limited and only few receive professional help. Internet-based cognitive behavioral therapy (ICBT) has been proposed to increase accessibility and reduce costs of treatment.Entities:
Year: 2019 PMID: 31532802 PMCID: PMC6750608 DOI: 10.1371/journal.pone.0222485
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Module content and homework practice tasks.
| Module title | Module content | Homework practice tasks |
|---|---|---|
| 1. Understanding anxiety | • How to use the program | • Complete an anxiety self-assessment questionnaire to get overview of present anxiety issues |
| 2. Setting goals | • Learning to set goals | • Identify goals |
| 3. Realistic thinking I | • Linking thoughts and feelings | • Practice realistic thinking |
| 4. Stepladders I | • Identifying and categorizing fears and worries | • Create the first stepladder |
| 5. Stepladders II | • Revising old and creating new stepladders | • Create more stepladders |
| 6. Realistic thinking II | • Simplifying realistic thinking (in my mind) | • Make list of useful questions and thoughts for realistic thinking |
| 7. Other coping skills | • Problem solving | • Practice problem solving and assertiveness |
| 8. Staying chilled | • Skills overview and maintenance | • Continue to practice skills |
Note. Table originally published in Stjerneklar et al. [57]
Fig 1Study flow-chart.
Sample characteristics.
| ICBT (n = 35) | Waitlist (n = 35) | Total (N = 70) | |
|---|---|---|---|
| Females (%) | 29 (83) | 26 (74) | 55 (79) |
| Adolescent age, M (SD) | 15.22 (1.32) | 14.83 (1.28) | 15.03 (1.30) |
| Living with both parents (%) | 23 (66) | 27 (77) | 50 (71) |
| Parent age, mothers/fathers, M (SD) | 45.86/48.84 (4.47/5.92) | 46.31/47.09 (4.50/4.64) | 46.08/47.95 (4.46/5.34) |
| Level of education of mothers/fathers (%) | |||
| University / Doctoral degree | 7/8 (20/23) | 4/9 (11/26) | 11/17 (16/24) |
| Vocational / College | 26/23 (74/66) | 31/19 (89/54) | 57/42 (81/60) |
| Primary / High school | 2/0 (6/0) | 0/3 (0/9) | 2/3 (3/4) |
| NA | 0/4 (0/11) | 0/4 (0/11) | 0/8 (0/11) |
| Annual household income in Euro, M (SD) | 79566.99 (33885.81) | 108829.05 (39124.18) | 94198.02 (39207.54) |
| >150.000 (%) | 0 (0) | 6 (17) | 6 (9) |
| 100.000–149.999 (%) | 12 (34) | 14 (40) | 26 (37) |
| 50.000–99.999 (%) | 15 (43) | 14 (40) | 29 (41) |
| <50.000 (%) | 8 (23) | 1 (3) | 9 (13) |
| Age of anxiety onset | 8.6 (4.16) | 9.2 (3.47) | 8.9 (3.81) |
| Primary diagnoses (%) | |||
| Social phobia | 14 (40) | 14 (40) | 28 (40) |
| Generalized anxiety disorder | 6 (17) | 5 (14) | 11 (16) |
| Specific phobia | 4 (11) | 2 (6) | 6 (9) |
| Obsessive-compulsive disorder | 3 (9) | 5 (14) | 8 (11) |
| Separation anxiety disorder | 2 (6) | 7 (20) | 9 (13) |
| Panic disorder | 3 (9) | 0 (0) | 3 (4) |
| Panic disorder with AP | 1 (3) | 1 (3) | 2 (3) |
| AP without panic disorder | 2 (6) | 1 (3) | 3 (4) |
| Comorbid diagnoses (%) | |||
| Anxiety disorders | 29 (83) | 22 (63) | 51 (73) |
| Mood disorders | 3 (9) | 3 (9) | 6 (9) |
| Externalizing disorders | 0 (0) | 0 (0) | 0 (0) |
| No comorbidity | 5 (14) | 12 (34) | 17 (24) |
| Number of anxiety diagnoses per adolescent, M (SD) | 2.29 (0.93) | 1.94 (0.91) | 2.11 (0.93) |
| On psychopharmacological medication (%) | 5 (14) | 2 (6) | 7 (10) |
| Previous therapeutic treatment (%) | 21 (60) | 22 (63) | 43 (61) |
Note. AP: Agoraphobia
a Age of onset is based on the mean age from mother and father reports.
Program activity and support for the ICBT condition, completer sample (n = 33); mean (SD) {range}.
| Mean duration | Mean duration | |||||||
|---|---|---|---|---|---|---|---|---|
| 5.4 (2.37) | 74.4 (23.17) | 24.4 (10.57) | 11.0 (1.93) | 19.5 (8.80) | 0.2 (0.65) | 1.3 (0.64) | 24.0 (10.62) | 0.6 (1.23) |
Note. #: number; T/A: between therapist and adolescent; T/P: between therapist and parent.
a Components activated is reported as percentages per module
b Duration is reported in minutes
Frequency of improvement and recovery for the intention-to-treat sample; n (%).
| Post-treatment | 3-month f/up | 12-month f/up | |
|---|---|---|---|
| Free of primary diagnosis | |||
| ICBT | 14/35 (40%) | 12/33 (36%) | - - |
| WL | 5/32 (16%) | ||
| Free of all anxiety diagnoses | |||
| ICBT | 10/35 (29%) | 10/33 (30%) | - - |
| WL | 1/32 (3%) | ||
| Improved (SCAS-Cadol) | |||
| ICBT | 22/32 (69%) | 18/27 (67%) | 12/25 (48%) |
| WL | 8/31 (26%) | ||
| Recovered (SCAS-Cadol) | |||
| ICBT | 14/32 (44%) | 14/27 (52%) | 10/25 (40%) |
| WL | 2/31 (6%) | ||
| Improved (SCAS-Pmother) | |||
| ICBT | 24/35 (69%) | 23/33 (70%) | 20/31 (65%) |
| WL | 7/32 (22%) | ||
| Recovered (SCAS-Pmother) | |||
| ICBT | 9/35 (26%) | 13/33 (39%) | 14/31 (45%) |
| WL | 2/32 (6%) | ||
| Improved (SCAS-Pfather) | |||
| ICBT | 9/25 (35%) | 14/23 (61%) | 14/21 (67%) |
| WL | 5/27 (19%) | ||
| Recovered (SCAS-Pfather) | |||
| ICBT | 1/25 (4%) | 7/23 (30%) | 9/21 (43%) |
| WL | 2/27 (7%) |
Note. SCAS-C/P: Spence Children’s Anxiety Scale Child/Parent version. f/up: follow-up.
Means, standard deviations and effect sizes of primary and secondary outcomes.
| Unadjusted mean (standard deviation) {valid n} | Effect size; | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Pre-treatment | Post-treatment | 3-month f/up | 12-month f/up | Within-group | Within-group | Between-group | Within-group | Within-group | |
| pre to post | pre to f/up | ICBT vs. WL | post to 3 f/up | 3 to 12 f/up | |||||
| ADIS CSRprim | |||||||||
| ICBT | 6.69 (0.68) {35} | 3.83 (2.65) {35} | 3.88 (2.56) {33} | ||||||
| WL | 6.54 (0.92) {35} | 5.09 (2.29) {32} | |||||||
| ADIS CSRall | |||||||||
| ICBT | 13.17 (5.28) {35} | 6.89 (4.56) {35} | 6.39 (4.64) {33} | ||||||
| WL | 11.17 (4.42) {35} | 9.28 (4.13) {32} | |||||||
| SCAS-Cadol | |||||||||
| ICBT | 47.29 (15.38) {35} | 31.88 (16.06) {32} | 28.74 (16.08) {27} | 33.36 (12.64) {25} | |||||
| WL | 45.60 (15.79) {35} | 40.19 (19.90) {31} | |||||||
| SCAS-Pmother | |||||||||
| ICBT | 48.23 (17.28) {35} | 29.43 (13.60) {35} | 28.73 (16.57) {33} | 28.58 (18.58) {31} | |||||
| WL | 42.71 (14.85) {35} | 41.31 (17.54) {32} | |||||||
| SCAS-Pfather | |||||||||
| ICBT | 41.45 (19.18) {31} | 32.46 (17.29) {26} | 28.33 (15.33) {24} | 23.55 (18.77) {22} | |||||
| WL | 37.41 (12.75) {32} | 36.96 (14.35) {27} | |||||||
| CALISadol | |||||||||
| ICBT | 13.54 (6.56) {35} | 10.59 (7.65) {32} | 8.93 (7.63) {27} | 9.72 (8.55) {25} | |||||
| WL | 13.97 (6.73) {35} | 12.42 (8.65) {31} | |||||||
| CALISmother | |||||||||
| ICBT | 32.14 (11.36) {35} | 22.49 (12.67) {35} | 23.21 (16.33) {33} | 20.61 (14.96) {31} | |||||
| WL | 33.71 (11.91) {35} | 35.34 (13.47) {32} | |||||||
| CALISfather | |||||||||
| ICBT | 29.42 (14.07) {31} | 25.89 (15.58) {27} | 24.21 (14.53) {24} | 16.59 (13.50) {22} | |||||
| WL | 28.91 (9.74) {32} | 28.52 (13.00) {27} | |||||||
| WHO-5 | |||||||||
| ICBT | 44.69 (21.44) {35} | 49.50 (21.69) {32} | 55.85 (25.21) {27} | 48.48 (25.98) {25} | |||||
| WL | 48.91 (19.19) {35} | 54.06 (20.39) {31} | |||||||
| S-MFQadolescent | |||||||||
| ICBT | 10.46 (6.47) {35} | 8.06 (7.77) {32} | |||||||
| WL | 10.94 (7.07) {35} | 7.77 (7.14) {31} | |||||||
| S-MFQmother | |||||||||
| ICBT | 9.91 (5.79) {35} | 5.77 (5.25) {35} | |||||||
| WL | 10.43 (6.15) {35} | 9.47 (6.37) {32} | |||||||
| S-MFQfather | |||||||||
| ICBT | 8.26 (5.43) {31} | 7.15 (5.86) {27} | |||||||
| WL | 7.88 (4.89) {32} | 6.56 (4.85) {27} | |||||||
| SEQ-Ctotal | |||||||||
| ICBT | 70.71 (13.88) {35} | 75.25 (16.55) {32} | |||||||
| WL | 71.23 (15.76) {35} | 74.00 (16.27) {31} | |||||||
| SEQ-Cacademic | |||||||||
| ICBT | 27.17 (7.14) {35} | 27.13 (8.04) {32} | |||||||
| WL | 26.11 (8.49) {35} | 26.71 (7.84) {31} | |||||||
| SEQ-Csocial | |||||||||
| ICBT | 25.09 (5.46) {35} | 26.06 (6.11) {32} | |||||||
| WL | 26.20 (6.79) {35} | 27.06 (6.32) {31} | |||||||
| SEQ-Cemotional | |||||||||
| ICBT | 18.46 (5.92) {35} | 22.06 (5.87) {32} | |||||||
| WL | 18.91 (5.26) {35} | 20.23 (6.35) {31} | |||||||
Note. ADIS: Anxiety Disorder Interview Schedule for DSM-IV; CSR: Clinical Severity Rating; SCAS-C/P: Spence Children’s Anxiety Scale Child/Parent version; CALIS: Child Anxiety Life Inference Scale; WHO-5: WHO-5 Well-being Index Questionnaire; S-MFQ: short version of the Moods and Feelings Questionnaire; SEQ-C: The Self-Efficacy Questionnaire for Children; f/up: follow-up.
a Pre to 3-month follow-up
b Pre to 12-month follow-up. For the SCAS, CALIS and S-MFQ, a family-wise Bonferroni-corrected significance level of p = 0.017 was deployed. Effect size calculations based on observed values and expressed as Cohen’s d. Positive effect sizes indicate improvement.
Fig 2Mean CSR pre-post for primary diagnosis.
Fig 3Mean CSR pre-post for sum of all anxiety diagnoses.
Fig 4Mean SCAS total scores at pre, post, 3- and 12-month follow-up for adolescents, mothers and fathers.